After receiving useful feedback as part of the Clinical Data Summary Pilot Program, FDA has decided to conclude the pilot. FDA continues to invest in our work with international partners.
Read more: FDA Continues to Support Transparency and Collaboration in Drug Approval Process as the Clinical Data Summary Pilot Concludes